Note: This post was written by Claude Opus 4.7. The following is a synthesis of Medscape’s “Most Popular Specialties for Doctors Report 2026” and reporting on it from Radiology Business.
A new Medscape physician survey puts radiology at the top of the list of specialties optimistic about their short-term future and at 18th on the same list when the time horizon stretches out. The 27-percentage-point drop is one of the largest in the dataset, and it is the most interesting finding in the report.
The survey, written up by Medscape’s Jennifer Nelson on April 21 and covered by Radiology Business on April 27, polled nearly 6,000 physicians across about 30 specialties between September and December 2025. The radiology subsample was 177 doctors. Respondents rated their specialty’s prospects on a 5-point scale; “optimistic” was a 4 or 5 on that scale.
What the data shows
Optimism over the next three years:
- Radiology: 69%, first place
- Oncology: 67%
- Otolaryngology: 66%
Optimism over a longer horizon:
- Oncology: 70%, first place
- Psychiatry: 57%
- Plastic surgery: 55%
- Radiology: 42%, eighteenth
Sixteen of the 29 specialties Medscape examined had a majority of practitioners optimistic about the next three years. Only four specialties had a majority optimistic about the longer term. Internal medicine landed at the very bottom of the long-term list, at 20%.
On the pessimism side, only 8% of radiologists called themselves pessimistic about the next three years; 22% were pessimistic about the longer-term outlook. Nephrology drew the most short-term pessimism at 43%. As one survey respondent put it: “Nephrologists are slowly being marginalized.” For the long term, OB-GYN, internal medicine, and family medicine all topped 40% pessimism.
When physicians were asked to rate the appeal of all specialties to today’s medical students and residents, dermatology and orthopedics tied for first at 54%. Radiology came in sixth at 27%, tied with emergency medicine. The drivers of perceived appeal were money first (potential compensation cited by 71%), then work-life balance (57%), reimbursement (53%), and career prospects/job security (45%).
What the gap might mean
The 27-point drop in radiology between the short-term and long-term optimism numbers is bigger than the corresponding drop for most specialties in the survey. Oncology and psychiatry, by contrast, hold their optimism steady or close to it across both horizons. Whatever radiologists are seeing over the next three years, they are not seeing in the same shape over a longer time frame.
Medscape notes the radiology decline as worrisome but stops short of attributing a cause. The survey did not ask radiologists to explain the gap, so any analysis is inference.
The most obvious candidate, given the public conversation around the field, is artificial intelligence. Radiology has been the target of “AI will replace this profession” predictions for the better part of a decade. The actual growth has been in clearances that augment radiologists rather than replace them: the FDA has authorized more than 1,400 AI-enabled medical devices since it began tracking, and roughly three-quarters of them, 1,104 of 1,451 through the end of 2025, are in radiology. The radiology share of new clearances has held between 73% and 80% every year for the past three years. By a wide margin, radiology is the largest commercial AI category in healthcare. AI-assisted reading and worklist triage are now routine in many practices and have measurably increased the cases a single radiologist can move through in a shift, which is consistent with elevated short-term optimism.
The longer-horizon drop-off is consistent with a different read: the productivity tailwind eventually flips into a workforce headwind. If AI continues to compress the per-case time investment, fewer radiologists may be needed for the same case volume. None of that is in the survey itself. What the survey does establish is that radiologists themselves see a meaningful difference between the next three years and what comes after.
The setting, not the specialty
The other finding worth pulling out of the report, across all specialties and not just radiology, is the disconnect between satisfaction with one’s specialty and satisfaction with one’s practice setting. Seventy-three percent of respondents said they would choose medicine again, 76% would choose the same specialty, but only 30% would choose the same practice setting.
Medscape’s framing of that gap is sharper than most:
One in 5 would abandon both their specialty and their practice setting, suggesting that private equity consolidation, hospital employment, administrative burden, and loss of autonomy may be the real culprits that would prompt physicians to bail if given a do-over.
Physicians may be more at peace with who they are and what they do but increasingly at war with the systems in which they must do it.
For radiology specifically, that overlay matters. Radiology has seen substantial consolidation over the last decade through private-equity-backed national groups, large hospital-system imaging departments, and remote-staffing arrangements. If practice setting is the structural complaint, then “what kind of radiology practice will exist in ten years” is at least as load-bearing for the long-term-optimism number as “how good will AI be at preliminary reads in ten years.”
A neurosurgeon quoted in the Medscape report, Arthur L. Jenkins, III, MD, made the point in plainer terms about his own specialty: “I do feel my specialty is in crisis right now. The primary driver of that crisis is the consolidation of private practice doctors into employed medicine environments and managing the business and clinical aspects on their own.”
That is one specialty, not radiology, but the structural forces are the same.
Sources
- Radiology Business — Radiologists among docs most optimistic about profession’s short-term future (Marty Stempniak, April 27, 2026)
- Medscape — The Race for Relevance: Most Popular Specialties for Doctors Report 2026 (Jennifer Nelson, April 21, 2026)
- The Imaging Wire — Numbers from the FDA show radiology is maintaining its lead (March 11, 2026): the per-year breakdown of FDA AI/ML medical-device clearances showing radiology’s 73-80% share.